Stimulation_NN
of_IN
human_JJ
lymphocyte_NN
proliferation_NN
and_CC
CD40_NN
antigen_NN
expression_NN
by_IN
phosphorothioate_JJ
oligonucleotides_NNS
complementary_JJ
to_TO
hepatitis_NN
B_NN
virus_NN
genome_NN
._.

We_PRP
have_VBP
studied_VBN
the_DT
proliferation_NN
and_CC
CD40_NN
antigen_NN
expression_NN
of_IN
lymphocytes_NNS
,_,
and_CC
the_DT
cytotoxicity_NN
to_TO
monocytes_NNS
,_,
of_IN
antisense_JJ
phosphorothioate_NN
oligodeoxynucleotides_NNS
complementary_JJ
to_TO
the_DT
SP_NN
II_CD
promoter_NN
of_IN
HBV_NN
mRNA_NN
-LRB-_-LRB-
sequence_NN
I_CD
-RRB-_-RRB-
and_CC
the_DT
X_NN
gene_NN
-LRB-_-LRB-
sequence_NN
II_CD
-RRB-_-RRB-
in_IN
patients_NNS
with_IN
chronic_JJ
hepatitis_NN
B_NN
._.

The_DT
oligo_JJ
sequence_NN
I_NN
stimulated_VBD
proliferation_NN
of_IN
both_DT
T_NN
and_CC
,_,
to_TO
a_DT
lesser_JJR
extent_NN
,_,
B_NN
cells_NNS
._.

The_DT
percentage_NN
of_IN
cells_NNS
expressing_VBG
CD40_NN
in_IN
T_NN
and_CC
B_NN
cell_NN
co-cultures_NNS
increased_VBD
from_IN
4.2_CD
%_NN
to_TO
13.8_CD
%_NN
after_IN
oligo_JJ
stimulation_NN
in_IN
patients_NNS
,_,
while_IN
it_PRP
increased_VBD
form_VB
4.7_CD
%_NN
to_TO
48.6_CD
%_NN
in_IN
healthy_JJ
controls_NNS
._.

The_DT
sense_JJ
sequence_NN
-LRB-_-LRB-
sequence_NN
III_CD
-RRB-_-RRB-
of_IN
the_DT
X_NN
gene_NN
also_RB
enhanced_VBD
the_DT
expression_NN
of_IN
CD40_NN
antigen_NN
in_IN
patients_NNS
with_IN
hepatitis_NN
B_NN
._.

The_DT
proportion_NN
of_IN
CD40_NN
cells_NNS
-LRB-_-LRB-
26_CD
%_NN
-RRB-_-RRB-
in_IN
a_DT
resting_VBG
B-cell_NN
preparation_NN
from_IN
hepatitis_NN
B_NN
patients_NNS
decreased_VBD
to_TO
zero_CD
after_IN
a_DT
5-day_JJ
culture_NN
with_IN
sequence_NN
I_NN
,_,
but_CC
IgG_NN
levels_NNS
in_IN
the_DT
culture_NN
supernatant_NN
increased_VBD
._.

The_DT
cytotoxic_JJ
properties_NNS
of_IN
monocytes_NNS
were_VBD
not_RB
influenced_VBN
by_IN
the_DT
oligos_NNS
._.

These_DT
findings_NNS
indicate_VBP
that_IN
antisense_JJ
oligos_NNS
against_IN
hepatitis_NN
B_NN
virus_NN
-LRB-_-LRB-
HBV_NN
-RRB-_-RRB-
have_VBP
mitogenic_JJ
effects_NNS
on_IN
the_DT
proliferation_NN
of_IN
human_JJ
lymphocytes_NNS
in_IN
a_DT
non-specific_JJ
manner_NN
and_CC
may_MD
activate_VB
T_NN
cells_NNS
to_TO
express_VB
CD40_NN
antigen_NN
._.

